Skip to main content
×
Home
    • Aa
    • Aa

Perioperative Intranasal Mupirocin for the Prevention of Surgical-Site Infections: Systematic Review of the Literature and Meta-Analysis

  • Alexander J. Kallen (a1) (a2), Chad T. Wilson (a1) (a2) and Robin J. Larson (a1) (a2)
Abstract
AbstractObjective:

To review the evidence evaluating perioperative intranasal mupirocin for the prevention of surgical-site infections according to type of surgical procedure.

Design:

Systematic review and meta-analysis of published clinical trials.

Setting:

Studies included were either randomized clinical trial or prospective trials at a single institution that measured outcomes both before and after an institution-wide intervention (before-after trial). In all studies, intervention and control groups differed only by the use of perioperative intranasal mupirocin in the intervention group.

Patients:

Patients undergoing general or nongeneral surgery (eg, cardiothoracic surgery, orthopedic surgery, and neurosurgery).

Main Outcome Measure:

Risk of surgical-site infection following perioperative intranasal mupirocin versus usual care.

Results:

Three randomized and four before-after trials met the inclusion criteria. No reduction in surgical-site infection rate was seen in randomized general surgery trials (summary estimates: 8.4% in the mupirocin group and 8.1% in the control group; relative risk [RR], 1.04; 95% confidence interval [CI95], 0.81 to 1.33). In nongeneral surgery, the use of mupirocin was associated with a reduction in surgical-site infection in randomized trials (summary estimates: 6.0% in the mupirocin group and 7.6% in the control group; RR, 0.80; CI95, 0.58 to 1.10) and in before-after trials (summary estimates: 1.7% in the mupirocin group and 4.1% in the control group; RR, 0.40; CI95, 0.29 to 0.56).

Conclusions:

Perioperative intranasal mupirocin appears to decrease the incidence of surgical-site infection when used as prophylaxis in nongeneral surgery. Given its low risk and low cost, use of perioperative intranasal mupirocin should be considered in these settings.

Copyright
Corresponding author
VA Outcomes Group, 215 North Main Street, VA Medical Center, White River Junction, VT 05009, Alexander.J.Kallen@dartmouth.edu
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2. R Nichols . Preventing surgical site infections: a surgeon's perspective. Emerg Infect Dis 2001;7:220224.

3. W Martone , R Nichols . Recognition, prevention, surveillance and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 2001;33:S67S68.

5. RP Wenzel , TM Perl . The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 1995;31:1324.

7. MW Casewell . The nose: an underestimated source of Staphylococcus aureus causing wound infection. J Hosp Infect 1998;40(suppl B):S3S11.

8. BN Doebbeling , DL Breneman , HC Neu , et al.Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. Clin Infect Dis 1993;17:466474.

9. TM Perl . Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis. Surgery 2003;134:S10S17.

10. C Fernandez , C Gaspar , A Torrellas , et al.A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel. J Antimicrob Chemother 1995;35:399408.

11. TC Horan , RP Gaynes , W Martone , WR Jarvis , TG Emori . CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606608.

12. GE Cimochowski , MD Harostock , R Brown , M Bernardi , N Alonzo , K Coyle , Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 2001;71:15721578.

13. TM Perl , JJ Cullen , RP Wenzel , et al.Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002;346:18711877.

14. RP Harris , M Helfand , SH Woolf , et al.Current methods of the U.S. Preventive Services Task Force: a review of the process. Am J Prev Med 2001;20:2135.

15. MD Kalmeijer , H Coertjens , PM van Nieuwland-Bollen , et al.Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002;35:353358.

16. Y Suzuki , T Kamigaki , Y Fujino , M Tominaga , Y Ku , Y Kuroda . Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery. Br J Surg 2003;90:10721075.

17. JA Kluytmans , JW Mouton , MF VandenBergh , et al.Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996;17:780785.

18. M Yano , Y Doki , M Inoue , T Tsujinaka , H Shiozaki , M Monden . Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with Staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg Today 2000;30:1621.

19. AJ Gernaat-van der Sluis , AM Hoogenboom-Verdegaal , PJ Edixhoven , NH Spies-van Rooijen . Prophylactic mupirocin could reduce orthopedic wound infections: 1,044 patients treated with mupirocin compared with 1,260 historical controls. Acta Orthop Scand 1998;69:412414.

20. KB Laupland , JM Conly . Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence based review. Clin Infect Dis 2003;37:933938.

21. MF VandenBergh , JA Kluytmans , BA van Hout , et al.Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol 1996;17:786792.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 4 *
Loading metrics...

Abstract views

Total abstract views: 96 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 28th June 2017. This data will be updated every 24 hours.